肌少症与脆性骨折的关系:一项系统综述
该系统综述检索PubMed和Cochrane数据库,纳入15篇文献,总结脆性骨折患者中肌少症的患病率及肌少症患者发生脆性骨折的相关危险因素。骨折后肌少症患病率男性为12.4%至95%,女性为18.3%至64%;两项研究显示肌少症合并低骨密度时是脆性骨折的危险因素,但仅见于男性。
要点
- 脆性骨折后肌少症患病率男性12.4%至95%,女性18.3%至64%。
- 肌少症合并低骨密度时是脆性骨折的危险因素,但仅见于男性。
- 对肌少症合并低骨密度的男性患者应谨慎,其骨折风险显著增加。
核心结论
- 脆性骨折老年患者中肌少症患病率较高,尤其是男性。
- 两项研究显示肌少症合并低骨密度时是脆性骨折的危险因素,但仅见于男性。
- 对肌少症合并低骨密度的男性患者应谨慎,其与骨折风险显著增加相关。
- 亟需进一步研究肌少症及其脆性骨折风险,以更好地理解两者关系、病理生理和机制,可能为改善临床结局的潜在干预提供线索。
研究设计与样本
- 系统综述,检索PubMed和Cochrane数据库。
- 共纳入15篇文献,其中10篇报告肌少症患病率,5篇报告肌少症患者的骨折风险。
主要发现
- 骨折后肌少症患病率男性为12.4%至95%,女性为18.3%至64%。
- 两项研究显示肌少症合并低骨密度时是脆性骨折的危险因素,但仅见于男性。
关键数值与推荐
- 纳入标准为报告老年脆性骨折患者肌少症患病率及肌少症患者相关危险因素的研究。
临床怎么用
- 对肌少症合并低骨密度的男性患者应谨慎,其与骨折风险显著增加相关。
局限性
- 亟需进一步研究肌少症及其脆性骨折风险,以更好地理解两者关系、病理生理和机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Sarcopenia is a common geriatric syndrome characterized by progressive decrease of muscle mass and function leading to an increased risk of physical disability, poor quality of life, and mortality. Increasing evidence shows that sarcopenia is related with fragility fractures. This systematic review aimed to summarize the following: (1) the prevalence of sarcopenia in patients with fragility fracture and (2) the associated risk factors for fragility fracture in patients with sarcopenia. Literature search was conducted in PubMed and Cochrane databases. Studies with the prevalence of sarcopenia in elderly patients with fragility fracture and associated risk factors in patients with sarcopenia were included. A total of 15 papers were included, with 10 reporting sarcopenia prevalence, and 5 on fracture risk in patients with sarcopenia. The prevalence of sarcopenia after fracture ranged from 12.4 to 95% in males and 18.3 to 64% in females. The prevalence of sarcopenia in elderly patients with fragility fracture was high, especially in men. Two studies showed that sarcopenia was a risk factor for fragility fracture when associated with low bone mineral density (BMD) but only in men. Caution should be taken for male patients with sarcopenia and low BMD, which is related to significantly increased risk of fractures. There is a pressing need for further research on sarcopenia and its risk on fragility fracture to better understand the relationship, pathophysiology, and mechanisms, which may shed light on potential interventions to improve clinical outcomes.
引用
- Wong RMY, Wong H, Zhang N, et al. The relationship between sarcopenia and fragility fracture-a systematic review. Osteoporos Int. 2019. PMID: 30610245. doi:10.1007/s00198-018-04828-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。